Traditional Medicine

Overview

India is one of the few countries where traditional medicine systems operate alongside modern biomedicine at scale. The AYUSH framework — comprising Ayurveda, Yoga, Unani, Siddha, and Homeopathy — represents centuries of accumulated therapeutic knowledge, institutionalized after independence and given constitutional recognition through the creation of a dedicated ministry in 2014. Over 770,000 registered AYUSH practitioners serve an estimated 600 million patients annually, making traditional medicine not a marginal alternative but a core component of India's health infrastructure.

Yet this plurality sits uneasily within a regulatory and epistemological framework dominated by evidence-based medicine. The central tension is this: can systems rooted in humoral theory, elemental balance, and personalized constitutional types be validated by randomized controlled trials designed for standardized chemical compounds? And if not, what standards of safety, efficacy, and quality control should apply? These questions are not merely academic — they determine whether AYUSH medicines reach patients as regulated therapeutics or as unregulated commercial products of uncertain composition.

The AYUSH Systems

Ayurveda

The oldest and most widely practiced of India's traditional systems, Ayurveda — "the science of life" — dates back at least 3,000 years. Its theoretical foundation rests on the tridosha model: vata (air/space), pitta (fire/water), and kapha (water/earth). Health is defined as balance among the doshas; disease as their disturbance. Treatment encompasses herbal formulations (kaashtha aushadhi and rasa aushadhi), dietary regulation, Panchakarma (purification therapies), and lifestyle modification.

• Institutional base: Over 400 undergraduate and 100 postgraduate Ayurvedic colleges; the Institute of Post Graduate Teaching and Research in Ayurveda (IPGTRA) in Jamnagar is a premier institution.
• Pharmaceutical scale: The Ayurvedic drug industry is valued at approximately ₹300 billion, with major players like Dabur, Himalaya, and Patanjali. However, the sector is highly fragmented, with an estimated 8,000 licensed manufacturers and a vast unregulated cottage industry.
• Global reach: Ayurveda is recognized in over 30 countries. The WHO's inclusion of traditional medicine in the International Classification of Diseases (ICD-11) in 2019 gave Ayurveda a formal diagnostic vocabulary for global use.

Yoga

While often treated as a physical fitness regimen in the West, Yoga in its Indian context is a comprehensive philosophy and therapeutic system. The Yoga Sutras of Patanjali (c. 400 CE) codified an eight-limbed path (ashtanga) aimed at mental and spiritual liberation. In public health, Yoga's relevance lies in its evidence-backed efficacy for stress reduction, chronic pain management, cardiovascular health, and mental well-being.

• Institutionalization: The Morarji Desai National Institute of Yoga (MDNIY) in New Delhi and over 50 Yoga therapy centres across government hospitals integrate Yoga into mainstream care.
• International recognition: The UN's declaration of June 21 as International Day of Yoga (2015) reflects India's successful diplomacy in positioning Yoga as a global public good. The WHO recognizes Yoga as a legitimate complementary therapy for non-communicable diseases.
• Research base: The Central Council for Research in Yoga and Naturopathy (CCRYN) funds clinical trials. Meta-analyses have confirmed benefits for hypertension, diabetes, anxiety, and lower back pain.

Unani

Unani Tibb (Greco-Arab medicine) was brought to India during the Delhi Sultanate and flourished under the Mughals. Based on Hippocratic humoral theory and Galenic medicine, it emphasizes the akhlat (humours: blood, phlegm, yellow bile, black bile) and the tabiyat (innate healing power of the body). Treatment includes herbal medicines (mulookhiyat), dietary regimens, and regimental therapies (ilaj bit tadbeer) such as cupping, massage, and exercise.

• Geographic concentration: Strongest in Uttar Pradesh, Bihar, Maharashtra, Madhya Pradesh, and Andhra Pradesh. The Central Council for Research in Unani Medicine (CCRUM) operates 24 research centres and 3 hospitals.
• Education: ~70 Unani colleges, primarily in the northern and Deccan regions. Hamdard University (New Delhi) and Aligarh Muslim University are prominent.
• Pharmaceuticals: Major manufacturers include Hamdard (Rooh Afza, Safi, Joshina) and Ajmal. The Unani pharmacopeia contains over 1,100 standardized formulations.

Siddha

Indigenous to Tamil Nadu and parts of Sri Lanka, Siddha medicine is one of India's oldest documented systems, traditionally attributed to the 18 Siddhars (enlightened sages). Its theoretical framework shares concepts with Ayurveda (tridosha, five elements) but places unique emphasis on muppu (three salts) and alchemical preparations involving metals and minerals.

• Distinctive feature: Siddha's extensive use of rasamani (metallic and mineral preparations), including mercury-based compounds, raises significant safety concerns. The system claims sophisticated detoxification (purification) procedures, but these are not consistently standardized.
• Institutional base: The Government Siddha Medical College in Chennai and 7 other colleges. The National Institute of Siddha (Chennai) is the apex research and clinical centre.
• Regulatory challenge: Siddha medicines fall under the Drugs and Cosmetics Act, but enforcement of quality standards for metal-based preparations remains weak. Adverse event reporting is minimal.

Homeopathy

Introduced to India in the early 19th century by German missionaries and physicians, Homeopathy found fertile ground in Bengal and spread nationwide. Based on Samuel Hahnemann's principle of similia similibus curentur (like cures like) and the use of highly diluted remedies, it remains deeply popular despite persistent scientific controversy over its plausibility mechanism.

• Scale: India has the largest Homeopathic infrastructure in the world: ~250,000 registered practitioners, 225 colleges, 7,000 dispensaries, and 300 hospitals. The Central Council for Research in Homeopathy (CCRH) conducts clinical trials and maintains drug standardization laboratories.
• Integration: Homeopathy is integrated into the National Health Mission; AYUSH doctors are posted at PHCs and CHCs in several states. The government recognizes Homeopathy as a valid system of medicine under the National Commission for Homoeopathy (NCH) Act, 2020.
• Scientific debate: Systematic reviews (Lancet, 2005; NHMRC, 2015) have found no robust evidence that Homeopathy is superior to placebo for any condition. Defenders argue that conventional trial designs are ill-suited to individualized Homeopathic prescribing.

Ministry of AYUSH

The Ministry of AYUSH was established as an independent ministry in November 2014, elevating the former Department of AYUSH from under the Ministry of Health and Family Welfare. This was both a political and institutional statement: traditional medicine was no longer to be treated as a subsidiary of biomedicine but as a parallel system deserving its own policy architecture.

• Mandate: Education standardization, research promotion, drug quality control, international cooperation, and integration of AYUSH into public health programmes. The ministry oversees five statutory councils: CCIM (Ayurveda & Siddha), CCH (Homeopathy), CCUM (Unani), and the newly formed National Commission for Indian System of Medicine (NCISM) and National Commission for Homoeopathy (NCH) under the 2020 acts.
• Budget: The ministry's budget has grown from ₹1,069 crore (2014–15) to ₹3,000+ crore (2024–25), reflecting increased political priority. Major schemes include the AYUSH Health and Wellness Centres (HWCs) under Ayushman Bharat, the AYUSH Grid (digital infrastructure), and the WHO Global Centre for Traditional Medicine in Jamnagar (Gujarat), inaugurated in 2022.
• WHO Global Centre for Traditional Medicine: Hosted in Jamnagar, this is the first and only WHO centre dedicated to traditional medicine globally. It aims to synthesize evidence, set standards, and support countries in integrating traditional medicine into national health systems.
• Criticism: Public health experts have criticized the ministry for prioritizing cultural nationalism over scientific rigour, particularly during the COVID-19 pandemic when AYUSH remedies were promoted without robust clinical evidence. The line between "promoting indigenous knowledge" and "endorsing unproven therapies" remains politically charged.

Integration with Modern Medicine

The integration of AYUSH into India's formal health system has proceeded along three axes: co-location (AYUSH facilities alongside allopathic hospitals), practice integration (AYUSH practitioners in NHM programmes), and pharmaceutical integration (herbal drug development and standardization). The goal is a "pluralistic" health system where patients can choose or combine systems based on condition, preference, and evidence.

• AYUSH Health and Wellness Centres: Under Ayushman Bharat, 1.5 lakh HWCs are to provide comprehensive primary care, including Yoga and AYUSH services. As of 2024, ~75,000 HWCs are operational, though staffing and supply gaps are significant.
• Mainstreaming AYUSH in NHM: AYUSH doctors are posted at PHCs and CHCs in underserved areas, particularly in Rajasthan, Madhya Pradesh, Chhattisgarh, and Uttarakhand. They provide primary care, maternal health services, and disease prevention. However, tensions with allopathic practitioners over scope of practice are common.
• Cross-practice: The question of whether AYUSH practitioners can prescribe allopathic drugs has been legally and politically contentious. Several states have passed laws allowing integrated practice ("bridge courses"), struck down by the Supreme Court in 2018 as violating the Indian Medical Council Act. The National Medical Commission (NMC) has resisted formal cross-practice, though informal collaboration is widespread.
• Herbal drug development: The CSIR-Traditional Knowledge Digital Library (TKDL) documents 350,000 traditional formulations to prevent biopiracy. The New Millennium Indian Technology Leadership Initiative (NMITLI) has supported modern drug discovery from Ayurvedic leads, though no blockbuster drug has yet emerged.

Challenges

Despite institutional support and popular acceptance, AYUSH systems face structural challenges that limit their contribution to public health:

• Quality control: A 2018 study published in JAMA found that 21% of Ayurvedic and Siddha medicines purchased online contained detectable levels of lead, mercury, or arsenic. The Ayurvedic Pharmacopoeia and Good Manufacturing Practice (GMP) standards exist, but enforcement is weak, especially in the unorganized sector. The absence of pre-market toxicity testing for metal-based preparations is a major regulatory gap.
• Evidence base: While Yoga has accumulated a robust evidence base, clinical trials for Ayurvedic and Homeopathic medicines often suffer from methodological flaws (small sample sizes, lack of blinding, publication bias). The Ministry of AYUSH has increased funding for randomized controlled trials, but the research culture — dominated by institutional loyalty over sceptical inquiry — produces studies designed to confirm efficacy rather than test it rigorously.
• Standardization: Traditional medicines are inherently variable: the chemical composition of a plant extract depends on soil, climate, harvest time, and processing method. Standardizing these into reproducible pharmaceuticals is technically challenging and economically costly. The concept of "standardization" itself is contested — Ayurvedic practitioners argue that personalization is the point, not standardization.
• Commercialization and quackery: The popularity of AYUSH has spawned a massive unregulated market of "wellness" products, miracle cures, and unqualified practitioners. Patanjali's claims during COVID-19 (Coronil as a cure) were retracted after legal challenges, but such episodes damage public trust and blur the line between medicine and marketing.
• Workforce quality: AYUSH education varies enormously in quality. Many colleges lack adequate clinical exposure, research training, and modern diagnostic skills. Graduates often struggle to integrate into multidisciplinary health teams because their training lacks epidemiology, biostatistics, and evidence-based medicine.

Sources